C07D 295/10
Substituted by doubly bound oxygen or sulphur atoms
Official title: substituted by doubly bound oxygen or sulphur atoms
C07D295/10 (Substituted by doubly bound oxygen or sulphur atoms) appears on 666 US grants and 546 published applications in this corpus.
Search patents in C07D- Granted patents
- 666
- Published applications
- 546
- Assignees
- 461
- Inventors
- 2,180
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 19 | 0 |
| 1977 | 17 | 0 |
| 1978 | 10 | 0 |
| 1979 | 10 | 0 |
| 1980 | 11 | 0 |
| 1981 | 9 | 0 |
| 1982 | 16 | 0 |
| 1983 | 8 | 0 |
| 1984 | 17 | 0 |
| 1985 | 15 | 0 |
| 1986 | 12 | 0 |
| 1987 | 8 | 0 |
| 1988 | 13 | 0 |
| 1989 | 10 | 0 |
| 1990 | 16 | 0 |
| 1991 | 9 | 0 |
| 1992 | 14 | 0 |
| 1993 | 5 | 0 |
| 1994 | 5 | 0 |
| 1995 | 7 | 0 |
| 1996 | 5 | 0 |
| 1997 | 5 | 0 |
| 1998 | 10 | 0 |
| 1999 | 9 | 0 |
| 2000 | 14 | 0 |
| 2001 | 11 | 3 |
| 2002 | 23 | 21 |
| 2003 | 14 | 31 |
| 2004 | 18 | 26 |
| 2005 | 9 | 24 |
| 2006 | 10 | 27 |
| 2007 | 15 | 22 |
| 2008 | 15 | 26 |
| 2009 | 13 | 23 |
| 2010 | 14 | 26 |
| 2011 | 15 | 23 |
| 2012 | 14 | 20 |
| 2013 | 21 | 12 |
| 2014 | 15 | 28 |
| 2015 | 19 | 24 |
| 2016 | 23 | 32 |
| 2017 | 31 | 28 |
| 2018 | 20 | 23 |
| 2019 | 15 | 21 |
| 2020 | 13 | 24 |
| 2021 | 16 | 14 |
| 2022 | 16 | 20 |
| 2023 | 16 | 9 |
| 2024 | 7 | 15 |
| 2025 | 3 | 15 |
| 2026 | 6 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Multifunctional cytoprotectant for treatment of pathogenic processes mediated by oxidative stress and toxic electrophiles4 Aug 2026US 12,697,310 B2Montefiore Medical Center
- Substituted 3-amino-4-methylbenzenesulfonamides as small molecule inhibitors of ubiquitin-specific protease 2830 Jun 2026US 12,668,571 B2Dana-Farber Cancer Institute, Inc.
- Chemical compounds and uses thereof23 Jun 2026US 12,662,451 B2Glaxosmithkline Intellectual Property (No. 4) Ltd.
- Structurally modified opioids for prevention and treatment of diseases and conditions26 May 2026US 12,637,411 B2Mggm LLC
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives21 Apr 2026US 12,606,522 B2OrsoBio, Inc.
- Novel compounds with mtorc2-inhibitory activity and uses thereof10 Sep 2026US 2026/0265267 A1Aliad Biopharma
- Heterocycloalkyl beta-hydroxy alkyl amines for use in the treatment of hyperglycaemia and disorders characterised by hyperglycaemia20 Aug 2026US 2026/0242335 A1Atrogi AB
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives16 Jul 2026US 2026/0200844 A1OrsoBio, Inc.
- Triazine compound salt, crystal form thereof, and production method therefor25 Jun 2026US 2026/0176240 A1Tanabe Pharma Corporation
- Compounds and compositions for nematode treatment18 Jun 2026US 2026/0165319 A1Iowa State University Research Foundation, Inc.
Most cited
By later US patents
- Acrylamido functional disubstituted acetyl aryl ketone photoinitiators213US 5,506,279 AMinnesota Mining and Manufacturing Company · 1996
- Photoactivatable water soluble cross-linking agents containing an onium group198US 5,714,360 ABSI Corporation · 1998
- Sensitizers for photopolymerization190US 4,308,400 ACiba-Geigy Corporation · 1981
- Sigma receptor ligands and the use thereof150US 6,057,371 AVirginia Commonwealth University · 2000
- Compounds with activity on muscarinic receptors147US 6,528,529 B1ACADIA Pharmaceuticals Inc. · 2003